Key result
Insulin infusion and triglyceride apheresis appeared to have equal therapeutic potential for the treatment of hypertriglyceridemia-induced acute pancreatitis.
Cohort (n=12)
No
Objectives: We aimed to research the superiority of insulin infusion and triglyceride apheresis for the treatment of hypertriglyceridemia-induced acute pancreatitis (HIAP).Patients and methods: In this retrospective, single-center cohort study, demographic data, clinical and biochemical parameters of HIAP were retrieved from the medical record database. The clinical data of 12 patients with HIAP were retrospectively analyzed.Results: The indication and timing of intervention and which treatment modality in HIAP is most efficacious remains unclear. We want to highlight our experience that seems to be equal therapeutic potential of both options.Conclusion: In treatment of HIAP, comorbidities should be taken into consideration and treatment should be personalized. More studies are needed to help define the best treatment option for HIAP.
No takes yet. Share an insight, caveat, or question.
Utku Erdem Soyaltın (2015) conducted a cohort in Hypertriglyceridemia-induced acute pancreatitis (n=12). Insulin infusion vs. Triglyceride apheresis was evaluated. Insulin infusion and triglyceride apheresis appeared to have equal therapeutic potential for the treatment of hypertriglyceridemia-induced acute pancreatitis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: